Immortalization of American miniature horse-derived fibroblast by cell cycle regulator with normal karyotype.
- Journal Article
Summary
This research has successfully created stable, continuously dividing ‘immortal’ cells from an American Miniature Horse using specific human-derived proteins. Immortalized cells like these can provide important insights into genetic and physiological characteristics of the animal.
Research Objective
The objective of this research was to establish a stable, ‘immortal’ cell line from fibroblasts (a common type of cell found in connective tissues) derived from an American Miniature Horse. These immortalized cells significantly contribute to ongoing research as they can proliferate indefinitely, providing important insights into the animal’s genetic and physiological traits.
Methodology
The researchers accomplished immortalization by expressing certain proteins in the horse cells. Specifically:
- They used a mutated form of human-derived cyclin-dependent kinase 4 (CDK4R24C), along with cyclin D1 and Telomerase Reverse Transcriptase (TERT) — all crucial components in controlling cell division and longevity.
- They also attempted to achieve immortalization using a combination of CDK4R24C, cyclin D1, SV40T (a viral protein), and TERT, but this approach was not successful.
Findings
Outcomes of the research were as follows:
- The combination of CDK4R24C, cyclin D1, and TERT was successful in creating an immortalized fibroblast cell line from a miniature horse.
- A key feature of these immortalized cells is that they maintained a normal karyotype, meaning the number and appearance of their chromosomes remain typical which is crucial to ensure that the cells behave and respond in a way similar to normal cells in the body.
- The alternative combination including SV40T was not successful in immortalizing the cells.
Conclusion
The researchers managed to establish an immortalized cell line with a “normal” karyotype from an American miniature horse. This accomplishment opens the way for further research on these animals’ genetic and physiological traits, yielding potentially valuable information for targeted interventions to improve their health and well-being.
Cite This Article
Publication
Researcher Affiliations
- Department of Advanced Bioscience, Kindai University, Nara, Nara, Japan.
MeSH Terms
- Horses / genetics
- Humans
- Animals
- United States
- Cyclin D1 / genetics
- Cell Line
- Cell Cycle / genetics
- Karyotype
- Fibroblasts
Conflict of Interest Statement
References
- Virology. 1984 Sep;137(2):414-21
- J Biotechnol. 2014 Apr 20;176:50-7
- Clinics (Sao Paulo). 2021 Feb 05;76:e2432
- J Cell Biochem. 2006 May 15;98(2):267-86
- PLoS One. 2020 Mar 2;15(3):e0229996
- Sci Rep. 2014 Feb 13;4:4089
- PLoS One. 2019 Aug 26;14(8):e0221364
- Reprod Domest Anim. 2008 Jul;43 Suppl 2:331-7
- In Vitro Cell Dev Biol Anim. 2021 Dec;57(10):998-1005
- Anticancer Res. 1996 Sep-Oct;16(5A):2681-6
- J Neurosci Methods. 2009 Jan 30;176(2):112-20
- BMC Cell Biol. 2007 Jun 01;8:20
- Biol Proced Online. 2017 Oct 18;19:13
- Oncogene. 1998 Mar 5;16(9):1217-22
- EMBO J. 1989 Dec 1;8(12):3905-10
- Oncogene. 2005 Nov 21;24(52):7729-45
- Cytotechnology. 2018 Dec;70(6):1619-1630
- Sci Rep. 2018 Jun 20;8(1):9229
- Biochem Biophys Res Commun. 2000 Nov 30;278(3):503-10
- Sci Rep. 2020 Dec 16;10(1):22047
- Biol Reprod. 2002 Aug;67(2):442-6
- Biochem Biophys Res Commun. 2020 May 14;525(4):1046-1053
- Cytotechnology. 2016 Oct;68(5):1937-47
- J Cell Physiol. 2019 May;234(5):6709-6720
- Chromosoma. 2012 Oct;121(5):475-88
- iScience. 2020 Dec 11;24(1):101929
- Annu Rev Anim Biosci. 2016;4:223-53
- J Reprod Dev. 2017 Jun 21;63(3):311-318
- Cytotechnology. 2022 Feb;74(1):181-192
- Nucleic Acids Res. 2020 Apr 17;48(7):3657-3677
- Science. 1998 Dec 11;282(5396):2095-8
- J Immunol. 2014 Jun 15;192(12):5933-42
- Anim Genet. 2010 Dec;41 Suppl 2:159-65
- Clin Immunol. 2022 May;238:108998
- PeerJ. 2019 Sep 16;7:e7678